...The companies partnered to combine Cell Signaling's reagents, including phospho-specific antibodies, with Zeptosens' ZeptoMark protein microarray...
...for protein expression analysis and protein activation profiling. Cell Signaling Technology Inc. , Beverly, Mass. Zeptosens AG...

...Mass.) and Zeptosens (Witterswil, Switzerland) partnered to combine Cell Signaling's reagents, including phospho-specific antibodies, with Zeptosens'...

...oligonucleotide sets and microarrays such as the SensiChip system. SensiChip was developed by QIA and Zeptosens AG...

...oligonucleotide sets and microarrays such as the SensiChip system. SensiChip was developed by QGENF and Zeptosens...

...access to the ZeptoGene Workstation, a DNA microarray technology from QIA. The platform, developed with Zeptosens AG...

...the ZeptoGene Workstation, a DNA microarray technology from Qiagen (QGENF; NMarkt:QIA). The platform, developed with Zeptosens...

...granted AVE limited access to evaluate its ZeptoGene Workstation array platform. QIA's technology, developed with Zeptosens AG...

...Aventis (AVE) limited access to evaluate its ZeptoGene Workstation technology platform. QIA's technology, developed with Zeptosens...

...and hematology disorders; infectious disease and oncology play Pharmasset (Bridgetown, Barbados); and fluorescence-based bioassay company Zeptosens...

...property from the '015 patent. Also last week, ACLA licensed a microfluidics patent application from Zeptosens AG...